Logo image
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study
Journal article   Open access

Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study

Rubab F Malik, Yaqi Jia, Sherry G Mansour, Peter P Reese, Isaac E Hall, Sami Alasfar, Mona D Doshi, Enver Akalin, Jonathan S Bromberg, Meera N Harhay, …
Kidney360, v 2(8), pp 1296-1307
26 Aug 2021
PMID: 35369651
url
https://kidney360.asnjournals.org/content/kidney360/2/8/1296.full.pdfView
Published, Version of Record (VoR) Open
url
https://doi.org/10.34067/KID.0000862021View
Published, Version of Record (VoR) Open

Abstract

Adult Aged Diabetes Mellitus - epidemiology Humans Kidney Transplantation - adverse effects Male Middle Aged Postoperative Complications - epidemiology Risk Factors Transplant Recipients
post-transplant diabetes mellitus (PTDM) is a common complication after kidney transplant (KT). Most recent studies are single center with various approaches to outcome ascertainment. In a multicenter longitudinal cohort of 632 nondiabetic adult kidney recipients transplanted in 2010-2013, we ascertained outcomes through detailed chart review at 13 centers. We hypothesized that donor characteristics, such as sex, HCV infection, and kidney donor profile index (KDPI), and recipient characteristics, such as age, race, BMI, and increased HLA mismatches, would affect the development of PTDM among KT recipients. We defined PTDM as hemoglobin A1c ≥6.5%, pharmacological treatment for diabetes, or documentation of diabetes in electronic medical records. We assessed PTDM risk factors and evaluated for an independent time-updated association between PTDM and graft failure using regression. Mean recipient age was 52±14 years, 59% were male, 49% were Black. Cumulative PTDM incidence 5 years post-KT was 29% (186). Independent baseline PTDM risk factors included older recipient age ( <0.001) and higher BMI ( =0.006). PTDM was not associated with all-cause graft failure (adjusted hazard ratio (aHR), 1.10; 95% CI, 0.78 to 1.55), death-censored graft failure (aHR, 0.85; 95% CI, 0.53 to 1.37), or death (aHR, 1.31; 95% CI, 0.84 to 2.05) at median follow-up of 6 (interquartile range, 4.0-6.9) years post-KT. Induction and maintenance immunosuppression were not different between patients who did and did not develop PTDM. PTDM occurred commonly, and higher baseline BMI was associated with PTDM. PTDM was not associated with graft failure or mortality during the 6-year follow-up, perhaps due to the short follow-up time.

Metrics

5 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Urology & Nephrology
Logo image